Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

New molecular insights into CETP structure and function: a review.

Charles MA, Kane JP.

J Lipid Res. 2012 Aug;53(8):1451-8. doi: 10.1194/jlr.R027011. Epub 2012 Jun 7. Review.

2.

Structural and biophysical insight into cholesteryl ester-transfer protein.

Hall J, Qiu X.

Biochem Soc Trans. 2011 Aug;39(4):1000-5. doi: 10.1042/BST0391000. Review.

PMID:
21787337
3.

Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.

Yamashita S, Hirano K, Sakai N, Matsuzawa Y.

Biochim Biophys Acta. 2000 Dec 15;1529(1-3):257-75. Review.

PMID:
11111094
4.

Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.

Niesor EJ.

Curr Opin Lipidol. 2011 Aug;22(4):288-95. doi: 10.1097/MOL.0b013e3283475e00. Review.

PMID:
21587074
5.

Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reduction.

Schaefer EJ, Asztalos BF.

Curr Opin Lipidol. 2006 Aug;17(4):394-8. Review.

PMID:
16832162
6.

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

Chapman MJ, Le Goff W, Guerin M, Kontush A.

Eur Heart J. 2010 Jan;31(2):149-64. doi: 10.1093/eurheartj/ehp399. Epub 2009 Oct 12. Review.

7.

Cholesteryl ester transfer protein (CETP) inhibitors.

Hunt JA, Lu Z.

Curr Top Med Chem. 2009;9(5):419-27. Review.

PMID:
19519458
8.
9.

Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?

Schaefer EJ.

Curr Opin Lipidol. 2013 Jun;24(3):259-64. doi: 10.1097/MOL.0b013e3283612454. Review.

PMID:
23652567
10.

Cholesteryl ester transfer protein and its inhibition.

Weber O, Bischoff H, Schmeck C, Böttcher MF.

Cell Mol Life Sci. 2010 Sep;67(18):3139-49. doi: 10.1007/s00018-010-0418-3. Epub 2010 Jun 18. Review.

PMID:
20556633
11.

[Advances on the research of the relationship between cholesteryl ester transfer protein and atherosclerosis].

Huang ZY, Guo HW.

Wei Sheng Yan Jiu. 2005 Nov;34(6):765-7. Review. Chinese.

PMID:
16535859
12.

Molecular disorders of cholesteryl ester transfer protein.

Yamashita S, Arai T, Hirano K, Sakai N, Ishigami M, Nakajima N, Matsuzawa Y.

J Atheroscler Thromb. 1996;3(1):1-11. Review.

PMID:
9225233
13.

Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.

Mabuchi H, Nohara A, Inazu A.

Mol Cells. 2014 Nov;37(11):777-84. doi: 10.14348/molcells.2014.0265. Epub 2014 Nov 6. Review.

14.

Cholesterol ester transfer protein (CETP), postprandial lipemia and hypolipidemic drugs.

Kolovou GD, Anagnostopoulou KK, Kostakou PM, Mikhailidis DP.

Curr Med Chem. 2009;16(33):4345-60. Review.

PMID:
19835569
15.

Controversy on high density lipoprotein raising therapy.

Cucuianu M, Brudaşcă I.

Rom J Intern Med. 2010;48(2):111-6. Review.

PMID:
21428174
17.

HDL metabolism and atheroprotection: predictive value of lipid transfers.

Maranhão RC, Freitas FR.

Adv Clin Chem. 2014;65:1-41. Review.

PMID:
25233609
18.

[High-density lipoprotein (HDL) and cholesteryl ester transfer protein (CETP): role in lipid metabolism and clinical meaning].

Kleber ME, Grammer TB, März W.

MMW Fortschr Med. 2010 Jul 1;152 Suppl 2:47-55. Review. German.

PMID:
21591319
19.

CETP inhibition in cardiovascular risk management: a critical appraisal.

Dullaart RP, Dallinga-Thie GM, Wolffenbuttel BH, van Tol A.

Eur J Clin Invest. 2007 Feb;37(2):90-8. Review. Erratum in: Eur J Clin Invest. 2007 May;37(5):434.

PMID:
17217373
20.

Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.

Nagano M, Yamashita S, Hirano K, Takano M, Maruyama T, Ishihara M, Sagehashi Y, Kujiraoka T, Tanaka K, Hattori H, Sakai N, Nakajima N, Egashira T, Matsuzawa Y.

J Atheroscler Thromb. 2004;11(3):110-21. Review.

Items per page

Supplemental Content

Write to the Help Desk